| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 06/04/2009 | WO2008130642A3 Improved process for preparing clopidogrel |
| 06/04/2009 | US20090143599 Heterocyclic Fused Selenophene Monomers |
| 06/04/2009 | US20090143399 Protein Kinase Inhibitors |
| 06/04/2009 | US20090143378 Thienopyrimidine and thienopyridine kinase modulators |
| 06/04/2009 | CA2706574A1 Aminothiazole derivatives |
| 06/04/2009 | CA2706171A1 Fused indane compound |
| 06/03/2009 | EP2065388A1 Pyrazolopyrimidine derivative |
| 06/03/2009 | EP2064217A2 An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts |
| 06/03/2009 | EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 06/03/2009 | CN101448840A Tetrahydropyridothienopyrimidine compounds and methods of use thereof |
| 06/02/2009 | US7541463 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | CA2474205C E2 displacement assay for identifying inhibitors of hpv |
| 06/02/2009 | CA2436185C Method for obtaining 4-(n-alkylamine)-5, 6-dihydro-4h-thieno-(2,3-b)-thiopyran-2-sulfamide-7, 7-dioxides and intermediate products |
| 05/28/2009 | WO2009066326A2 Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts |
| 05/28/2009 | US20090137806 Dual nk1/nk3 receptor antagonists |
| 05/28/2009 | US20090137772 Nonlinear optical chromophores with stabilizing substituent and electro-optic devices |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137563 Process for the prepartion of olanzapine |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |
| 05/28/2009 | CA2706586A1 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 05/28/2009 | CA2706391A1 Spiropiperidines for use as tryptase inhibitors |
| 05/27/2009 | EP2062898A2 Spirocyclic cyclohexane derivatives |
| 05/27/2009 | EP2061765A2 Serine-threonine protein kinase and parp modulators |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | EP1907397A4 Method of preparing clopidogrel and intermediates used therein |
| 05/27/2009 | CN101443334A Anti-viral compounds |
| 05/27/2009 | CN100491382C Preparation process of clopidogre and its salt |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 05/26/2009 | US7538213 Condensation of molar excess of N-methylpiperazine with 4-amine-2-methyl-10H-thieno [2,3-b][1,5]benzodiazepine hydrochloride in dimethylsulfoxide; recovery and purification with methylene chloride |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/22/2009 | WO2009064848A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | WO2009063780A1 Organic transistor |
| 05/22/2009 | WO2009062930A1 Heterocyclic derivatives |
| 05/22/2009 | WO2009062288A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062258A1 N-containing heterocyclic compounds |
| 05/22/2009 | CA2705586A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2705312A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2703901A1 Heterocyclic derivatives |
| 05/22/2009 | CA2703600A1 N-containing heterocyclic compounds |
| 05/21/2009 | US20090131675 Methods for structural analysis of proteins |
| 05/21/2009 | US20090131658 Process for preparing Olanzapine form I |
| 05/21/2009 | US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131455 Heterocyclic derivatives |
| 05/21/2009 | US20090131429 Pharmaceutical compounds |
| 05/21/2009 | US20090131413 Thienopyrazole Derivative Having PDE7 Inhibitory Activity |
| 05/21/2009 | US20090131408 Organic Compounds |
| 05/21/2009 | US20090131407 Tetracyclic kinase inhibitors |
| 05/21/2009 | US20090131400 Immunosuppressant compounds and compositions |
| 05/20/2009 | EP2060575A1 Dihydrothienopyrimidines and their use in treating inflammatory diseases |
| 05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 05/20/2009 | CN101437828A MGLUR1 antagonists as therapeutic agents |
| 05/20/2009 | CN101437816A 2-aminopyridine analogs as glucokinase activators |
| 05/20/2009 | CN101437512A Glucokinase activators |
| 05/20/2009 | CN100488967C Process for preparing dibenzyl biotin |
| 05/19/2009 | US7534799 Pyridomorphinans, thienomorphinans and use thereof |
| 05/19/2009 | US7534797 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 05/19/2009 | US7534475 For preparation of thin phase retarder, such as wide-ranged polarization plate, which gives inverse wavelength distribution |
| 05/14/2009 | WO2009062044A2 Processes for the preparation of prasugrel, and its salts and polymorphs |
| 05/14/2009 | WO2009061699A1 Gamma secretase modulators |
| 05/14/2009 | WO2009061131A2 Novel tricyclic derivatives or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same |
| 05/14/2009 | WO2009037357A4 Benzimidazole nf- kappab inhibitors |
| 05/14/2009 | WO2008135770A3 Process for preparing dorzolam ide |
| 05/14/2009 | WO2008108742A3 Polymorphic forms of clopidogrel hydrobromide |
| 05/14/2009 | US20090124610 Pharmaceutical compounds |
| 05/14/2009 | CA2704698A1 Gamma secretase modulators |
| 05/13/2009 | EP2057170A2 Polymorphic forms of spirapril hydrochloride |
| 05/13/2009 | EP2057162A2 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 05/13/2009 | EP1841773A4 Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof |
| 05/13/2009 | EP1828197B1 NOVEL SUBSTITUTED THIOPHENEPYRIMIDINONE DERIVATIVES AS INHIBITORS OF 17ß-HYDROXYSTEROID DEHYDROGENASE |
| 05/13/2009 | CN101432261A N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 05/13/2009 | CN101429206A Hexa-hydrogen-1-sulpho-3, 4-diaza-cyclopentane[cd]indene-4-ketone and synthesis thereof |
| 05/13/2009 | CN101429205A Process for producing 3,4-enedioxy thiophene |
| 05/13/2009 | CN101429204A (3aS,4S,6aR)-4-(5'-oxo-hexyl)-tetrahydrochysene thiophene-[3,6-]imidazoline-2-ketone and synthesis thereof |
| 05/13/2009 | CN101429192A Novel method for producing chiral sulfoxide derivant |
| 05/13/2009 | CN101429156A Novel methods for producing 1,2,3,4-tetrahydrochysene-4,4-dimethyl quinoline and its derivant |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531482 Thieno-pyrimidine compounds having fungicidal activity |
| 05/07/2009 | WO2009059272A1 Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
| 05/07/2009 | WO2009058728A1 Thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | WO2009037001A3 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 05/07/2009 | US20090118522 Synthesis of Cyclopentadienedithiophene Derivatives |
| 05/07/2009 | US20090118500 Thiophene compounds and thrombopoietin receptor activators |
| 05/07/2009 | US20090118356 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118276 Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
| 05/07/2009 | CA2703978A1 Thiazole derivatives as protein kinase inhibitors |
| 05/06/2009 | EP2055698A1 Chromene compound |
| 05/06/2009 | EP2054419A2 Pyrimidinone derivatives and their use as a drug |
| 05/06/2009 | EP2054418A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 05/06/2009 | EP2054417A2 Fused thiophene derivatives as mek inhibitors |
| 05/06/2009 | EP1828199B1 Thieno-pyridine derivatives as gaba-b allosteric enhancers |
| 05/06/2009 | CN101426795A Process for preparing dorzolamide |
| 05/06/2009 | CN101426505A Dihydrothienopyrimidine for treating inflammatory disorders |
| 05/06/2009 | CN101423522A Diperylene-3,4,6,7:12,13,15,16-octocarboxylic tetraimides compounds and production method thereof |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |